SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Focused Visit (Care-plan review) — Joe Louis — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJoe Louis
Date of birth1914-05-13
IdentifiersMRN HR-BX002-SYN-TD; SSN (made up) 000-02-6639
Document date1969-10-26
AuthorDesmond Achterberg-Cole, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Fifteen-week review off the antipsychotic. [S]

History of Present Illness

Mr. Louis returns five weeks after his ten-week review. He finished the aripiprazole taper three weeks ago and has had no persecutory thoughts and no trouble sleeping. He completed twelve weeks of contingency management: 22 of 24 scheduled tests were done and 21 were negative, the positive one after his single day of use; he has had no cocaine since. On his trip last month he tested at a partner clinic and had his therapy session by phone. He will continue weekly therapy and a weekly urine test for now. His home readings average 124/78 mmHg. The tax clinic reviewed his records and found nothing owed; with the social worker he has a budget and has applied for veterans' health benefits. He would like his zoster and second hepatitis B vaccines today. [S]

ElementDetail
CocaineNone for eight weeks
Contingency managementTwelve weeks completed; 21 of 22 tests negative
AripiprazoleStopped three weeks ago; no return of symptoms
Home blood pressureAverage 124/78 mmHg
FinancesNothing owed; budget; veterans' benefits applied for

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy good; weight steady
CardiovascularNegativeNo chest pain, palpitations or ankle swelling
NeurologicalNegativeNo headaches or memory lapses
PsychiatricNegativeNo persecutory thoughts; sleeping well; no thoughts of suicide or of harming anyone

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with fentanyl test strips and instruction for him and anyone he lives withOne spray as needed for suspected overdose; repeat in 2 to 3 minutes if neededNasal route1969-07-13activeS
Aripiprazole 5 mg oral tablet, one tablet each morningOne tablet each morningOral route1969-07-20 to 1969-09-21completedS
Aripiprazole 2 mg oral tablet, one tablet each morning for two weeks, then stopOne tablet each morning for two weeks, then stopOral route1969-09-21 to 1969-10-05completedS
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet dailyOral route1969-08-10activeS
Sodium chloride 0.65% nasal spray, two sprays in each nostril as needed for congestionTwo sprays in each nostril up to every 4 hours as neededNasal route1969-08-03 to 1969-08-08completedS
Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for sore throat or aches, no more than 3,000 mg a dayOne or two tablets every 6 hours as needed, no more than 3,000 mg a dayOral route1969-08-03 to 1969-08-08completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1969-10-26Body height187cmS
1969-10-26Body weight101.6kgS
1969-10-26Body mass index (BMI) [Ratio]29.1kg/m2S
1969-10-26Systolic blood pressure126mm[Hg]S
1969-10-26Diastolic blood pressure78mm[Hg]S
1969-10-26Heart rate72/minS
1969-10-26Respiratory rate16/minS
1969-10-26Body temperature36.7CelS
1969-10-26Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1969-10-26Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
1969-10-26Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
1969-10-26Creatinine [Mass/volume] in Serum or Plasma1.12mg/dL0.74-1.35 mg/dLNormalS
1969-10-26Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1964)/1.73 sq M78mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1969-10-26Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
1969-10-26Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
1969-10-26Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]4{score}S

Physical Exam

Vital signs recorded on 1969-10-26; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 126/78, pulse 72; weight 101.6 kg, BMI 29.1
CardiovascularRegular rhythm; no murmur; no edema
NeurologicalNo abnormal movements
PsychiatricRelaxed; no delusional content

Problems

ProblemClinical statusVerificationCodeProvenance
Persecutory thoughts and poor sleep for about two months: a fixed belief that people are following him and plan to harm him, three to four hours of sleep a night, partial insight; cause under evaluationresolvedconfirmed R41.89S — Synthetic presenting problem anchored to his documented fears of a plot against his life; resolved into the diagnosis at the consultation. Not a claim about his real symptoms.
Cocaine use disorder, severe (seven of eleven DSM-5-TR criteria): intranasal cocaine most days for about a year, last use three days before intakeresolvedconfirmed F14.20S — Synthetic modern coding at intake; superseded at the consultation by the combined code once the psychotic disorder was diagnosed. Person-first language; not a claim about his real diagnosis.
Cocaine use disorder, severe, with cocaine-induced psychotic disorder (persecutory delusions during heavy use, persisting ten days after the last use, with no history of psychosis off cocaine, a normal examination and no evidence of a neurocognitive disorder); psychotic symptoms resolved within four weeks on aripiprazoleactiveconfirmed F14.250S — Synthetic modern diagnosis made at the consultation. Not a claim about his real diagnosis.
Raised blood pressure at intake (154/98 mmHg) three days after cocaine use, without a diagnosis of hypertension; home readings plannedresolvedconfirmed R03.0S — Synthetic presenting finding; resolved into a diagnosis of hypertension at four weeks.
Hypertension, stage 2, confirmed four weeks after the last cocaine use (clinic 146/92, home average 144/90 mmHg), with mild concentric left ventricular hypertrophy and a normal aortic root on echocardiography; treated with amlodipineactiveconfirmed I10S — Synthetic modern diagnosis made at the four-week visit.
Financial insecurity: years of tax debt from his time as a well-paid athlete, now settled, left him with no savings; irregular income from paid appearances; worry about money keeps him awakeactiveconfirmed Z59.86S — Synthetic social need anchored to his documented tax debt.
Acute viral upper respiratory infection (common cold) for three days; rapid tests negative for influenza and COVID-19; resolved within ten days without antibioticsresolvedconfirmed J06.9S — Synthetic acute illness; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
Self-managementCocaine use since the last visit (his own account), cravings and triggersEvery visitCompleted todayNo cocaine for eight weeks
LaboratoryUrine drug tests in contingency management, with fentanyl, and prize draws for negative resultsTwice weekly for twelve weeks, then at visitsCompleted todayTwelve weeks completed: 22 of 24 scheduled tests done, 21 negative; weekly tests continue
ExaminationPsychotic symptoms, insight and sleepEvery visitCompleted todayNo psychotic symptoms three weeks after stopping aripiprazole
Medication safetyAntipsychotic safety: weight, blood pressure, akathisia (Barnes scale) and abnormal movements (AIMS)Weight and akathisia at every visit while on treatment; AIMS at baseline and every six monthsNot indicatedAripiprazole stopped three weeks ago; weight 101.6 kg, back near baseline; no abnormal movements
LaboratoryFasting glucose or hemoglobin A1c and lipids on an antipsychoticBaseline, at four months, then yearlyNot indicatedOff aripiprazole before the four-month check; lipids and hemoglobin A1c will be repeated yearly for his cardiovascular risk
ExaminationBlood pressure in clinic and at homeEvery visit; home readings before diagnosis and after each changeCompleted todayClinic 126/78; home average 124/78 mmHg; at target
LaboratoryBasic metabolic panel on antihypertensive treatmentYearly, or after a changeCompleted todaySodium 140, potassium 4.3 mmol/L, creatinine 1.12 mg/dL, eGFR 78, glucose 92 mg/dL
SurveySuicide and violence risk review, safety plan and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or of harming anyone; 988 in his phone
Medication safetyNaloxone and fentanyl test strips on handEvery visitCompleted todayNaloxone and test strips still at home
SurveyDepression (PHQ-9) and anxiety (GAD-7)At baseline and every four weeks while in treatmentCompleted todayPHQ-9 3, item 9 scored 0; GAD-7 4
Self-managementCognitive behavioral therapyWeeklyCompleted todayThirteen sessions so far, one by phone while traveling
Self-managementFinances, social work and taxpayer servicesEvery visitCompleted todayNothing owed on review; budget in place; veterans' benefits applied for
Self-managementFamily involvement, only with his consentEvery visitCompleted todayHe has chosen to tell his family about his recovery himself; no clinic contact requested

Goal progress:

Immunizations given today: Hepatitis B vaccine (HepB-CpG), second of two doses; Recombinant zoster vaccine, first of two doses [S]

Guideline basis: The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2023); The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia (2020); Treatment for Stimulant Use Disorders (Treatment Improvement Protocol 33, updated 2021) (2021); 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Zoster vaccine and second hepatitis B dose given today. Review in three months; second zoster dose in two to six months; second hepatitis A dose in four months. Weekly therapy and urine tests. Call the clinic or 988 at any time. [S]